SEC Comment Letter for Pluri Inc. (PLUR) (CIK 0001158780) (PLUR) — May 21, 2020

Pluri Inc. (PLUR) (CIK 0001158780)
Date: May 21, 2020 · CIK: 0001158780 · Accession: 0000000000-20-004542

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-31392

Date

May 21, 2020

Author

Chen Franco-Yehuda

Form

UPLOAD

Company

Pluri Inc. (PLUR) (CIK 0001158780)

Letter

United States securities and exchange commission logo May 21, 2020 Chen Franco-Yehuda Chief Financial Officer Pluristem Therapeutics Inc. Matam Advanced Technology Park Building No. 5 Haifa, Israel, 3508409 Re:Pluristem Therapeutics Inc. Preliminary Proxy Statement on Schedule 14A Filed April 30, 2020 File No. 001-31392 Dear Ms. Franco-Yehuda: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Ron Ben-Bassat

Show Raw Text

United States securities and exchange commission logo
May 21, 2020
Chen Franco-Yehuda
Chief Financial Officer
Pluristem Therapeutics Inc.
Matam Advanced Technology Park
Building No. 5
Haifa, Israel, 3508409
Re:Pluristem Therapeutics Inc.
Preliminary Proxy Statement on Schedule 14A
Filed April 30, 2020
File No. 001-31392
Dear Ms. Franco-Yehuda:
            We have completed our review of your filing.  We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:       Ron Ben-Bassat

SecProbe.io